RIM
UTHR icon

Redwood Investment Management’s United Therapeutics UTHR Stock Holding History

Redwood Investment Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.17M Buy
+2,154
New +$1.21M 0.12% 147
2026
Q1 		– Sell
-2,235
Closed -$1.09M – 348
2025
Q4 		$1.09M Buy
+2,235
New +$1.04M 0.12% 185
2024
Q4 		– Sell
-4,522
Closed -$1.62M – 382
2024
Q3 		$1.62M Buy
4,522
+174
+4% +$58.8K 0.14% 187
2024
Q2 		$1.4M Buy
+4,348
New +$1.15M 0.12% 194

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Redwood Investment Management's UTHR Position: Q2 2026 in Review

Redwood Investment Management opened a new position in United Therapeutics (UTHR) in Q2 2026: 2,154 shares worth $1.17M. The stake represents 0.12% of the portfolio and ranks #147 among its holdings. This is a return to the name: Redwood Investment Management previously reported a position in UTHR as recently as Q4 2025.

Redwood Investment Management first reported a position in UTHR in Q2 2024 and has held it in 4 quarters since. The position peaked at $1.62M in Q3 2024. 884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Redwood Investment Management held 2,154 shares of United Therapeutics worth $1.17M as of Q2 2026.
  • United Therapeutics was a new Redwood Investment Management position in Q2 2026.
  • United Therapeutics made up 0.12% of Redwood Investment Management's portfolio in Q2 2026, its #147 holding.
  • Redwood Investment Management first reported a position in United Therapeutics in Q2 2024 and has held it in 4 quarters since.
  • Redwood Investment Management's United Therapeutics position peaked at $1.62M in Q3 2024.
  • 884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Redwood Investment Management's 13F filing for Q2 2026, filed 17 Aug 2026.